Adverse Changes in HbA1c, Body Weight and Insulin Use in People with Type 1 Diabetes Mellitus Following Dapagliflozin Discontinuation in the DEPICT Clinical Trial Programme
Titel:
Adverse Changes in HbA1c, Body Weight and Insulin Use in People with Type 1 Diabetes Mellitus Following Dapagliflozin Discontinuation in the DEPICT Clinical Trial Programme
Auteur:
Gordon, Jason Danne, Thomas Beresford-Hulme, Lee Bennet, Hayley Tank, Amarjeet Edmonds, Christopher Thorén, Fredrik Scheerer, Markus Florian McEwan, Phil